Administrative
行政的
基本信息
- 批准号:8405107
- 负责人:
- 金额:$ 9.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-06-22 至 2017-05-31
- 项目状态:已结题
- 来源:
- 关键词:Biological AssayBudgetsCenters for Disease Control and Prevention (U.S.)ClinicalCommunicationComplexDataDevelopmentDoseDrug KineticsEnsureEvaluationExpenditureGelGoalsGrantHIV-1HospitalsHumanHuman ResourcesIn VitroIndividualInstitutesInstructionMethodsNational Institute of Allergy and Infectious DiseaseParticipantPerceptionPerformancePessariesPharmacodynamicsPharmacologic SubstancePlayProgram EvaluationProgress ReportsReportingResearchResearch ActivityRoleScheduleScienceScientistSeminal fluidSummary ReportsSuppositoriesTechnologyTeleconferencesTenofovirTestingTimeLineU-Series Cooperative AgreementsUnited States National Institutes of HealthUniversitiesUtahVaginaWomanWritingcost effectivein vivo Modelmeetingsmembermicrobicidenew product developmentnext generationnon-nucleoside reverse transcriptase inhibitorsnonhuman primatenovelnovel strategiesproduct developmentprogramsrectalresearch and developmentsymposiumtoolvaginal fluid
项目摘要
PROJECT SUMMARY (See instructions):
The proposed Project includes a complex interplay of both microbicide product development with single agent and combination microbicide products uniquely delivered to both the vaginal and rectal compartments, as well as microbicide science advancement in which the active microbicides will be utilized as tools to better
understand microbicide dosing, pharmacokinetics and pharmacodynamics in explants, nonhuman primates and humans, and acceptability/user perception. The product development components consist of the dual acting entry and nonnucleoside reverse transcriptase inhibitor IQP-0528 (a pyrimidinedione with subnanomolar activity against clinical strains of HIV-1) used alone and in combination with tenofovir in dual
compartment (DuoGels) gels and smart suppository/pessary (Smart Suppository) delivery vehicles that will enable dosing in both vaginal and rectal compartments. We believe the potential advancements in product development (new microbicide agents, combination products, long lasting delivery technology, dual compartment delivery technology) and microbicide science (dosing estimation, pharmacokinetics,
pharmacodynamics, in vitro, ex vivo, and in vivo modeling, effects of seminal and vaginal fluids, acceptability testing methods) make this proposal both inherently novel and important to the field of microbicide science in regard to the development of the next generation of microbicide products. In whole, the Project also provides for the development of novel PK/PD assays, novel single and combination products, novel delivery strategies, and novel microbicide development advancements to better understand and prioritize the development and use of microbicide products. The Administrative Core will play a critical and essential role in ensuring the smooth integration of the various Projects and Cores included in this cooperative agreement
research program. The successful performance of this Project requires a high degree of communication and interaction between the various Projects, the Cores, and the Corporate Partner. The Administrative Core will be responsible for managing and enhancing this constructive and synergistic interplay between the participating scientific groups.
项目总结(见说明):
拟议项目包括杀微生物剂产品开发与单一药剂和组合杀微生物剂产品的复杂相互作用,这些产品独特地输送到阴道和直肠隔室,以及杀微生物剂科学进步,其中活性杀微生物剂将被用作更好地
了解杀微生物剂的剂量,药代动力学和药效学在外植体,非人灵长类动物和人类,和可接受性/用户感知。产品开发组成部分包括双重作用的进入和非核苷逆转录酶抑制剂IQP-0528(一种对HIV-1临床株具有亚纳摩尔活性的嘧啶二酮)单独使用和与替诺福韦联合使用,
在一些实施方案中,本发明提供了能够在阴道隔室和直肠隔室中给药的凝胶(DuoGels)和智能栓剂/阴道托(Smart Suppository)递送载体。我们相信,产品开发(新的杀微生物剂、组合产品、长效递送技术、双室递送技术)和杀微生物剂科学(剂量估计、药代动力学、
药效学、体外、离体和体内建模、精液和阴道液的作用、可接受性测试方法)使得该提议在开发下一代杀微生物剂产品方面对杀微生物剂科学领域既具有固有的新颖性又具有重要性。总的来说,该项目还提供了新的PK/PD测定,新的单一和组合产品,新的交付策略和新的杀微生物剂开发进展的开发,以更好地了解和优先考虑杀微生物剂产品的开发和使用。行政核心将在确保本合作协议中包含的各个项目和核心的顺利整合方面发挥关键和重要的作用
研究计划。本项目的成功实施需要各项目、核心和公司合作伙伴之间的高度沟通和互动。行政核心将负责管理和加强参与科学团体之间的这种建设性和协同作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Walter Buckheit其他文献
Robert Walter Buckheit的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Walter Buckheit', 18)}}的其他基金
Critical Path IND-enabling Studies, Regulatory, and Product Development
关键路径 IND 支持研究、监管和产品开发
- 批准号:
8405106 - 财政年份:2012
- 资助金额:
$ 9.54万 - 项目类别:
Determination of Dosing Concentrations of Formulated APIs using the MTSA
使用 MTSA 确定配方 API 的剂量浓度
- 批准号:
8404125 - 财政年份:2012
- 资助金额:
$ 9.54万 - 项目类别:
Development and Evaluation of Dual Compartment Combination Microbicides
双室组合杀菌剂的开发与评价
- 批准号:
8699496 - 财政年份:2012
- 资助金额:
$ 9.54万 - 项目类别:
Development and Evaluation of Dual Compartment Combination Microbicides
双室组合杀菌剂的开发与评价
- 批准号:
8862358 - 财政年份:2012
- 资助金额:
$ 9.54万 - 项目类别:
Development and Evaluation of Dual Compartment Combination Microbicides
双室组合杀菌剂的开发与评价
- 批准号:
8374028 - 财政年份:2012
- 资助金额:
$ 9.54万 - 项目类别:
Development and Evaluation of Dual Compartment Combination Microbicides
双室组合杀菌剂的开发与评价
- 批准号:
8494567 - 财政年份:2012
- 资助金额:
$ 9.54万 - 项目类别:
Development and Evaluation of Dual Compartment Combination Microbicides
双室组合杀菌剂的开发与评价
- 批准号:
9060880 - 财政年份:2012
- 资助金额:
$ 9.54万 - 项目类别:
Advanced Preclinical and Clinical Development and Regulatory Evaluations
先进的临床前和临床开发以及监管评估
- 批准号:
8132428 - 财政年份:2010
- 资助金额:
$ 9.54万 - 项目类别:
Discovery of drugs for use in the treatment and prevention of HIV infection using
发现用于治疗和预防 HIV 感染的药物
- 批准号:
7932473 - 财政年份:2010
- 资助金额:
$ 9.54万 - 项目类别:
Development of Antimicrobial Peptides as Topical Microbicides
抗菌肽作为局部杀菌剂的开发
- 批准号:
8092553 - 财政年份:2010
- 资助金额:
$ 9.54万 - 项目类别:
相似海外基金
Can megafauna shift the carbon and surface radiation budgets of the Arctic?
巨型动物群能否改变北极的碳和地表辐射预算?
- 批准号:
NE/W00089X/2 - 财政年份:2024
- 资助金额:
$ 9.54万 - 项目类别:
Research Grant
Resilience of pollinators in a changing world: impact of developmental environment on metabolism and energetic budgets in social and solitary bees
不断变化的世界中授粉媒介的复原力:发育环境对群居和独居蜜蜂新陈代谢和能量预算的影响
- 批准号:
BB/X016641/1 - 财政年份:2024
- 资助金额:
$ 9.54万 - 项目类别:
Research Grant
An innovative EDI data, insights & peer benchmarking platform enabling global business leaders to build data-led EDI strategies, plans and budgets.
创新的 EDI 数据、见解
- 批准号:
10100319 - 财政年份:2024
- 资助金额:
$ 9.54万 - 项目类别:
Collaborative R&D
Nutrient budgets as a tool for minimizing nitrogen and phosphorus losses from agricultural fields
养分预算作为最大限度减少农田氮磷损失的工具
- 批准号:
574867-2022 - 财政年份:2022
- 资助金额:
$ 9.54万 - 项目类别:
University Undergraduate Student Research Awards
Collaborative Research: ORCC: The role of bioenergetic budgets in defining elevation limits and modeling geographic ranges of species
合作研究:ORCC:生物能预算在定义海拔限制和建模物种地理范围中的作用
- 批准号:
2222475 - 财政年份:2022
- 资助金额:
$ 9.54万 - 项目类别:
Standard Grant
Collaborative Research: ORCC: The role of bioenergetic budgets in defining elevation limits and modeling geographic ranges of species
合作研究:ORCC:生物能预算在定义海拔限制和建模物种地理范围中的作用
- 批准号:
2222476 - 财政年份:2022
- 资助金额:
$ 9.54万 - 项目类别:
Continuing Grant
CNS Core: Small: Budgets, Budgets Everywhere: A Necessity for Safe Real-Time on Multicore
CNS 核心:小:预算,预算无处不在:多核安全实时的必要性
- 批准号:
2151829 - 财政年份:2022
- 资助金额:
$ 9.54万 - 项目类别:
Standard Grant
Sea-ice Snow Microbial Communities’ Impact on Antarctic Bromocarbon Budgets and Processes
海冰雪微生物群落对南极溴碳预算和过程的影响
- 批准号:
2031121 - 财政年份:2022
- 资助金额:
$ 9.54万 - 项目类别:
Standard Grant
Breathing streams: integrating aquatic emissions into carbon budgets
呼吸流:将水生排放纳入碳预算
- 批准号:
DE220100852 - 财政年份:2022
- 资助金额:
$ 9.54万 - 项目类别:
Discovery Early Career Researcher Award
Can megafauna shift the carbon and surface radiation budgets of the Arctic?
巨型动物群能否改变北极的碳和地表辐射预算?
- 批准号:
NE/W00089X/1 - 财政年份:2022
- 资助金额:
$ 9.54万 - 项目类别:
Research Grant